HealthMode digital clinical measures

HealthMode, Inc. (healthmode.com) powers next-generation clinical trials and works toward regulatory approval and market access for drugs, devices, and combination products by developing and delivering AI-enabled digital measurement methods for clinical trials and clinical care.

HealthMode’s client partners represent a diverse set of stakeholders including drug developers at large pharmaceutical companies, clinical researchers and practitioners at academic medical centers, and startups entering the space with novel capabilities.

HealthMode’s measurement techniques:
- Improve understanding of phenotype
- Streamline and provide assurance for screening and eligibility;
- Provide early detection and mitigation of adverse events; and
- Serve as sensitive, specific, objective, and low burden endpoints.

The HealthMode approach allows for meaningful integration of clinical trial data with real-world evidence and provides the basis for movement toward a patient-specific understanding of health and wellness.

Partner with us to:

• 

  Introduce continuous representative data collection

• 

  Ensure high frequency measurement to detect meaningful clinical change

• 

  Incorporate objective assessment of therapeutic progression & minimise subjectivity

• 

  Understand causal relationships between genetics, environment & disease

• 

  Minimise the gap between real world & clinical trials data

• 

  Model individual disease trajectory & precisely predict prognosis

Industry partners

Partner to co-develop digital solutions for evidence generation in your clinical trials

Scientific partners

Improve your research with our data modelling & product development capabilities

Patient communities

Participate in ground breaking remote research

Why HealthMode?

• Unique capabilities in the development of digital measures
• Exceptional machine learning, artificial intelligence
• Agility in the execution of studies & collaboration with clinical sites worldwide
• Regulatory & market access expertise in multiple geographies

What's your greatest clinical trial design challenge?

Let's collaborate to develop a solution